The first experimental drug to boost brain synapses lost in Alzheimer's disease has been developed by researchers at Sanford-Burnham Medical Research Institute. The drug, called NitroMemantine, combines two FDA-approved medicines ...
Jun 17, 2013
12
0
Over the past few decades, neuroscientists have made much progress in mapping the brain by deciphering the functions of individual neurons that perform very specific tasks, such as recognizing the location or color of an ...
May 20, 2013
1
0
(Medical Xpress)—Researchers have taken a key step towards recovering specific brain functions in sufferers of brain disease and injuries by successfully restoring the decision-making processes in monkeys.
Sep 13, 2012
0
0
Over the past two decades, scientists have shown that babies only a few months old have a solid grasp on basic rules of the physical world. They understand that objects can't wink in and out of existence, and that objects ...
May 26, 2011
0
0
New research by a team of University of Pennsylvania psychologists is helping to overturn the dominant theory of how children learn their first words, suggesting that it occurs more in moments of insight than gradually through ...
May 23, 2011
0
0
The capacity to adjust beliefs about one's actions and their consequences in a constantly changing environment is a defining characteristic of advanced cognition. Disruptions to this ability, however, can negatively affect ...
Jun 13, 2024
0
19
When we're told "This coffee is hot" upon being served a familiar caffeinated beverage at our local diner or cafe, the message is clear. But what about when we're told "This coffee is not hot"? Does that mean we think it's ...
May 30, 2024
0
38
Researchers at the University of Leeds and Lancaster University in the UK have identified a new potential target for the treatment of Alzheimer's disease—PDE4B. Their work is published in Neuropsychopharmacology.
Mar 26, 2024
0
21
In experiments with lab-grown brain cells and mouse models, scientists at Johns Hopkins Medicine say they have discovered that a cell surface protein called Lag3 is not only a biological target for FDA-approved drugs that ...
Feb 23, 2024
0
90
People with early Alzheimer's disease have difficulty turning when walking, according to a new study using virtual reality led by UCL researchers.
Oct 11, 2023
0
23
